Top stocks to buy today: Stock recommendations for June 20, 2025
Top stocks to buy today (AI image)
Stock market recommendations:
According to Bajaj Broking Research,
Paras Defence and Space Technologies, and Thirumalai Chemicals
are the top stock picks for today. Here's its view on Nifty, Bank Nifty and the top stock picks for June 20, 2025:
Index View: NIFTY
Investor sentiment remains fragile amid intensifying geopolitical tensions in the Middle East, which have catalyzed a rally in Brent crude prices.
This presents a significant macroeconomic overhang for India, given its substantial reliance on crude imports, thereby casting a shadow over forward earnings visibility for India Inc. Meanwhile, the US Federal Reserve, in its recent policy review, maintained the federal funds rate within the target range of 4.25%–4.50%, aligning with market consensus.
The Fed reiterated its forward guidance for 2025, signaling a data-dependent stance with no imminent pivot in sight.
On the domestic front, the benchmark index continues to exhibit a phase of time-wise correction, consolidating within a well-demarcated range of 24,400–25,200 for the fifth successive week. The price action suggests a lack of directional conviction, indicative of a range-bound market structure.
On the upside, 25,000 remains a critical supply zone. A sustained breakout and close above this resistance threshold could trigger momentum-driven upside towards the upper boundary of the consolidation band at 25,200.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Sunteck Sky Park, Mira Road - 2 & 3 BHK @ ₹1.33 Cr*
Sunteck Sky Park
Learn More
Undo
However, failure to absorb supply at this level may extend the prevailing sideways trajectory.
On the downside, immediate support is situated at 24,700. A decisive breach below this inflection point could intensify selling pressure, potentially dragging the index towards the lower end of the consolidation band in the 24,500–24,400 range.
Key support is anchored in the 24,500–24,400 zone, which marks a confluence of the 50-day EMA and the lower boundary of the five-week consolidation range, making it a crucial demand zone for the index.
Only a breach below the lower band amid further escalation of geopolitical tension will signal acceleration of the decline towards 24,000 levels.
NIFTY BANK
Bank Nifty continues to consolidate in a range as investors remain on the edge amid intensifying geopolitical tensions in the Middle East.
From a structural standpoint, a sustained breakout and close above the 56,000 psychological marks would be essential to unlock further upside potential, with the index likely to gravitate towards the 56,600–57,000 resistance zone. However, failure to clear this overhead supply zone could result in continued range-bound action, with price oscillating between 56,000 and 55,000, shifting market attention to stock-specific alpha generation.
On the flip side, a decisive break down below the 55,000 levels would negate the ongoing consolidation structure and trigger a corrective move towards the critical support cluster at 54,500–54,000. This zone represents a confluence of the 50-day Exponential Moving Average (EMA) and the key Fibonacci retracement zone of the prior impulse leg (53,483–57,049).
Stock Recommendations:
Paras Defence and Space Technologies
Buy in the range of Rs 1610-1645
Target
SL
Return
Time Period
Rs 1790
1528
10%
3 Months
The stock is at the cusp of breaking above the falling trendline joining the highs of May and June 2025 signaling resumption of up move and offers fresh entry opportunity.
The stock is currently seen rebounding after a base formation above the 20 days EMA signaling overall positive bias.
The daily 14 periods RSI has generated a buy signal moving above its nine periods average thus validating positive bias. We expect the stock to head higher towards 1790 levels in the coming months being the 61.8% retracement of the previous decline (1945-1540).
Thirumalai Chemicals
Buy in the range of Rs 286-294
Target
SL
Return
Time Period
Rs 319
272
10%
3 Months
The stock has recently generated a breakout above a rounding formation and is seen sustaining above the short- and medium-term moving averages thus supports the positive bias.
The daily MACD is in uptrend and is seen sustaining above its nine periods average signaling positive bias. We expect the stock to head towards 319 levels in the coming months being the 61.8% retracement of the entire decline (395-201).
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
44 minutes ago
- Time of India
After EVs, rockets, and social media, the world's richest man Elon Musk is now eyeing your wallet
Elon Musk , the world's richest man, is now setting his sights on the world of finance. After shaking up electric vehicles, space travel, and social media, Musk is preparing to launch financial services through his platform X—formerly known as Twitter. According to reports, Musk plans to introduce investment and trading features on X as part of his vision to transform it into a 'super app' akin to China's WeChat. The goal is to build a comprehensive financial ecosystem that enables users to carry out transactions—shopping, tipping, storing money, and more—without ever leaving the platform. As part of this plan, X is expected to roll out branded credit and debit cards, potentially as early as this year. The initiative will debut in the U.S., with global expansion to follow. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 23.7% Returns in last 5 years with Shriram Life's ULIP Shriram Life Insurance Undo Visa has already signed on as the platform's first payments partner. The service, dubbed X Money , will include a digital wallet and peer-to-peer payment functions. Users will be able to make purchases, store funds, and support content creators, all within the app. 'You will be able to go on X and conduct all your financial transactions on the platform,' X CEO Linda Yaccarino was quoted as saying at the Cannes Lions International Festival of Creativity. She described the effort as the foundation of 'a whole commercial and financial ecosystem that doesn't exist today.' Live Events However, the road ahead isn't without hurdles. Regulatory scrutiny, particularly around licensing and anti-money laundering compliance, could pose significant challenges to Musk's ambitions. X is also working to rebuild its advertising business after a mass exodus of advertisers following Musk's acquisition in 2022. Concerns over content moderation and brand safety had driven many advertisers away, with some ads appearing next to controversial content. Despite lingering doubts from some marketers, Yaccarino claims that 96% of pre-acquisition advertisers have returned. Research firm eMarketer forecasts that X will generate $1.9 billion in ad revenue in 2024 and $2.3 billion in 2025—still far from the $4.1 billion it earned in 2022. In December 2024, Yaccarino had teased several upcoming features including X TV, X Money, and Grok, an AI chatbot, signaling that 2025 could be a pivotal year in Musk's quest to turn X into a one-stop digital universe.
Time of India
an hour ago
- Time of India
SoftBank's Masayoshiih Son pitches $1 trillion US AI hub to TSMC and Trump team: Report
SoftBank Group Corp founder Masayoshi Son is seeking to team up with Taiwan Semiconductor Manufacturing Co for a trillion-dollar industrial complex in Arizona to build robots and artificial intelligence, Bloomberg News reported on Friday, citing people familiar with the matter. A commitment of $1 trillion is double that of the $500 billion "Stargate" project which seeks to build out data centre capacity across the US, funded by SoftBank, OpenAI and Oracle . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa For Sale in Dubai Might Surprise You Villas in Dubai | Search ads Learn More Undo SoftBank is keen to have TSMC involved in the project but it is not clear the Taiwanese company would be interested, Bloomberg reported on Friday. SoftBank declined to comment. TSMC did not immediately respond to a request for comment. The White House and US Department of Commerce did not immediately respond to requests for comment. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories
Time of India
an hour ago
- Time of India
EU bars Chinese firms from most medical device tenders
The European Union will bar Chinese companies from participating in EU public tenders for medical devices worth 60 billion euros or more ($68.9 billion) per year after concluding that EU companies are not given fair access in China. The measure announced by the European Commission on Friday is the first under the EU's International Procurement Instrument , which entered into force in 2022 and is designed to ensure reciprocal market access. The new restrictions are likely to increase tensions with Beijing inflamed by EU tariffs on China-built electric vehicles, Chinese measures against EU brandy and curbs on exports of rare earths that the EU wants resolved by an EU-China summit in July. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Air conditioners without external unit. (click to see prices) Air Condition | Search Ads Search Now The Commission said on Friday that it would exclude Chinese companies from EU government purchases above five million euros. An EU official said, guided by figures of Medtech Europe, the EU medical technology market was worth some 150 billion euros in 2023, with public procurement accounting for a 70% share. Contracts of over 5 million euros were only 4% of tenders, but made up some 60% by value, the official said. Live Events Successful bids will have to ensure they include no more than 50% of medical devices from China. If there are no alternative suppliers, the exclusion will not apply. EU members backed the plan earlier this month. The Commission has previously said it found "clear evidence" that China favoured Chinese devices for hospitals and its tender conditions led to abnormally low bids that profit-oriented companies could not offer. A Commission official said the ban would cover medical equipment including imaging equipment, artificial body parts and medical clothing. China's commerce ministry has previously described the proposed EU measures as "protectionist", urging the EU to be fair and transparent and for both sides to resolve differences through cooperation and dialogue. The Commission said China had not proposed any corrective action to remedy the situation, but an agreement was still possible.
